Stocks
REGENXBIO (RGNX) EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | 169.5 | -244.2 | -239.5 | -198.2 | -133.3 | -235.2 | ||
| Changes by years, y/y, % | -275% | -244% | -2% | -17% | -33% | +6.6% | |||
REGENXBIO. EBITDA US GAAP, bln rub
REGENXBIO. EBITDA US GAAP, changes, %
REGENXBIO. EBITDA US GAAP, sum by quarters, bln rub
REGENXBIO (RGNX) EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EBITDA, bln rub | ? | 18.6 | -56.0 | -44.9 | -51.0 | -77.5 | -235.2 | |
| Changes by years, y/y, % | -133% | +15% | -18% | +35% | -516% | |||
| Changes by quarters, q/q, % | -149% | -401% | -20% | +14% | +52% | |||
